Canada markets closed

TransCode Therapeutics, Inc. (RNAZ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8200+0.1130 (+15.98%)
At close: 04:00PM EDT
0.7853 -0.03 (-4.23%)
After hours: 07:57PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.76M
Enterprise Value 2.45M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.90
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.14

Trading Information

Stock Price History

Beta (5Y Monthly) -0.34
52-Week Change 3-99.72%
S&P500 52-Week Change 322.38%
52 Week High 3309.6000
52 Week Low 30.4200
50-Day Moving Average 30.6379
200-Day Moving Average 320.2687

Share Statistics

Avg Vol (3 month) 3442.98k
Avg Vol (10 day) 3655.05k
Shares Outstanding 55.81M
Implied Shares Outstanding 65.81M
Float 85.81M
% Held by Insiders 10.14%
% Held by Institutions 10.27%
Shares Short (Apr 15, 2024) 418.55k
Short Ratio (Apr 15, 2024) 40.06
Short % of Float (Apr 15, 2024) 40.32%
Short % of Shares Outstanding (Apr 15, 2024) 40.32%
Shares Short (prior month Mar 15, 2024) 4174.75k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Jan 16, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-190.26%
Return on Equity (ttm)-759.85%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -19.3M
Net Income Avi to Common (ttm)-18.55M
Diluted EPS (ttm)-4,144.3999
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.77M
Total Cash Per Share (mrq)0.48
Total Debt (mrq)450.57k
Total Debt/Equity (mrq)27.46%
Current Ratio (mrq)1.28
Book Value Per Share (mrq)2.62

Cash Flow Statement

Operating Cash Flow (ttm)-18.07M
Levered Free Cash Flow (ttm)-11.21M